Search Results - "McDermed, J E"

Anaemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade by STRUM, S.B., McDERMED, J.E., SCHOLZ, M.C., JOHNSON, H., TISMAN, G.

“…Objectives  To describe the incidence, time to onset and extent of anaemia occurring in patients with prostate cancer receiving combined hormone blockade (CHB)…”
Get full text

Dose ranging phase I study of the serotonin antagonist GR38032F for prevention of cisplatin-induced nausea and vomiting by Grunberg, S M, Stevenson, L L, Russell, C A, McDermed, J E

“…GR38032F is a specific 5-HT3 (serotonin) receptor antagonist with antiemetic activity in animal and early human studies. We performed a dose-ranging phase I…”
Get more information

Impact of NADiA ProsVue PSA slope on secondary treatment decisions after radical prostatectomy by Moul, J W, Chen, D Y T, Trabulsi, E J, Warlick, C A, Ruckle, H C, Porter, J R, Yoshida, J S, Adams, G W, Kella, N, Matsunaga, G S, Bans, L L, Sarno, M J, McDermed, J E, Triebell, M T, Reynolds, M A

“…BACKGROUND: Selecting appropriate candidates for postprostatectomy radiotherapy is challenging, because adverse pathological features cannot accurately predict…”
Get full text

Oral metoclopramide with or without diphenhydramine: potential for prevention of late nausea and vomiting induced by cisplatin by Grunberg, S M, Ehler, E, McDermed, J E, Akerley, W L

“…Late nausea and vomiting lasting 2-7 days occurs in 20%-68% of patients receiving cisplatin. We therefore studied the effects of oral metoclopramide given at…”
Get more information

High-dose intravenous metoclopramide versus combination high-dose metoclopramide and intravenous dexamethasone in preventing cisplatin-induced nausea and emesis: a single-blind crossover comparison of antiemetic efficacy by Strum, S B, McDermed, J E, Liponi, D F

“…We tested the safety and antiemetic effectiveness of intravenous (IV) dexamethasone (DXM) as an adjunct to high-dose IV metoclopramide (MCP) to prevent nausea…”
Get more information

Combination metoclopramide and dexamethasone: an effective antiemetic regimen in outpatients receiving non-cisplatin chemotherapy by Strum, S B, McDermed, J E, Streng, B R, McDermott, N M

“…In a pilot study a combination of metoclopramide and dexamethasone was administered to 29 patients receiving emetogenic chemotherapy. Metoclopramide was given…”
Get more information

Clinical pharmacokinetics of high-dose metoclopramide in cancer patients receiving cisplatin therapy by McDermed, J E, Cohen, J L, Joseph, C, Strum, S B

“…Using a sensitive and specific high-pressure liquid chromatographic (HPLC) assay, we measured serum levels of metoclopramide in 18 cancer patients receiving…”
Get more information

Intravenous metoclopramide: prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation by Strum, S B, McDermed, J E, Pileggi, J, Riech, L P, Whitaker, H

“…The authors tested the safety and efficacy of intravenous metoclopramide in the prevention of chemotherapy-induced nausea and vomiting. Those studied included…”
Get more information

Drug extravasation and the Port-a-Cath system by Strum, S B, McDermed, J E

Get more information

Intrathoracic Hodgkin's disease. A case presentation with multiple pulmonary nodules in the absence of mediastinal or hilar node disease by Strum, S B, Weiss, A, McDermed, J E, Rosen, V J

“…Patients with Hodgkin's disease (HD) most commonly present with peripheral lymph node enlargement. The finding of pulmonary parenchymal involvement is usually…”
Get more information

Examination of the correlation of serum metoclopramide levels with antiemetic efficacy in patients receiving cisplatin by GRUNBERG, S. M, MCDERMED, J. E, BERNSTEIN, L, COHEN, J. L

“…The existence of a threshold serum metoclopramide level above which total protection from cisplatin-induced vomiting is more likely to occur has been proposed…”
Get full text

Prognostic impact of post-prostatectomy PSA slope determined with a novel, nucleic acid detection immunoassay (NADiA ProsVue) for total PSA by Moul, J. W., Semmes, O. J., Vessella, R., McDermed, J. E., Lilja, H.

“…Abstract only 47 Background: ProsVue is an investigational PSA immunoassay whose reporter antibody is labeled with a synthetic DNA sequence. RT-PCR detects the…”
Get full text

Treatment of astrocytoma with a 5-day cisplatin infusion by Grunberg, S M, Bertram, J H, McDermed, J E, Apuzzo, M L

“…Although cisplatin may have intrinsic activity against astrocytoma, limited penetration into the central nervous system may severely curtail delivery of…”
Get more information

Treatment of side effects in patients receiving Iv metoclopramide by Strum, S B, McDermed, J E

Get more information

Intermittent Androgen Deprivation in Prostate Cancer Patients: Factors Predictive of Prolonged Time Off Therapy by Strum, Stephen B., Scholz, Mark C., McDermed, Jonathan E.

“…Objectives. We hypothesize that prostate cancer (PC) patients who achieve and maintain an undetectable prostate‐specific antigen (UD‐PSA) on androgen…”
Get full text

Metoclopramide as an antiemetic by Strum, S B, McDermed, J E

Get more information

Intravenous Metoclopramide: An Effective Antiemetic in Cancer Chemotherapy by Strum, Stephen B, McDermed, Jonathan E, Opfell, Richard W, Riech, Laraine P

“…An open-label clinical trial was conducted to test the safety and efficacy of intravenous metoclopramide monohydrochloride in preventing chemotherapy-induced…”
Get full text

High pressure liquid chromatographic analysis of metoclopramide in serum by COHEN, J. L, HISAYASU, G. H, MC DERMED, J. E, STRUM, S. B

“…Metoclopramide has recently been approved at dose levels of 1 to 2 mg/kg for the treatment of nausea and vomiting resulting from cancer chemotherapeutic…”
Get full text